Vanguard Health Care ETF (VHT)
| Assets | $17.81B |
| Expense Ratio | 0.09% |
| PE Ratio | 22.12 |
| Shares Out | 87.27M |
| Dividend (ttm) | $3.90 |
| Dividend Yield | 1.35% |
| Ex-Dividend Date | Sep 24, 2025 |
| Payout Frequency | Quarterly |
| Payout Ratio | 29.71% |
| Volume | 305,349 |
| Open | 290.20 |
| Previous Close | 290.22 |
| Day's Range | 288.09 - 290.52 |
| 52-Week Low | 234.11 |
| 52-Week High | 296.51 |
| Beta | 0.65 |
| Holdings | 402 |
| Inception Date | Jan 26, 2004 |
About VHT
Fund Home PageThe Vanguard Health Care ETF (VHT) is an exchange-traded fund that is based on the MSCI US IMI 25/50 Health Care indexThe fund tracks a market-cap-weighted index of US healthcare stocks VHT was launched on Jan 26, 2004 and is issued by Vanguard.
Top 10 Holdings
45.95% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 11.24% |
| AbbVie Inc. | ABBV | 5.23% |
| UnitedHealth Group Incorporated | UNH | 4.71% |
| Johnson & Johnson | JNJ | 4.53% |
| Mktliq 12/31/2049 | n/a | 4.09% |
| Merck & Co., Inc. | MRK | 3.49% |
| Abbott Laboratories | ABT | 3.48% |
| Thermo Fisher Scientific Inc. | TMO | 3.46% |
| Intuitive Surgical, Inc. | ISRG | 3.10% |
| Amgen Inc. | AMGN | 2.60% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Sep 24, 2025 | $1.0765 | Sep 26, 2025 |
| Jun 26, 2025 | $0.9619 | Jun 30, 2025 |
| Mar 25, 2025 | $0.9396 | Mar 27, 2025 |
| Dec 18, 2024 | $0.9188 | Dec 20, 2024 |
| Sep 27, 2024 | $1.1666 | Oct 1, 2024 |
| Jun 28, 2024 | $0.9656 | Jul 2, 2024 |
Performance
VHT had a total return of 7.52% in the past year, including dividends. Since the fund's inception, the average annual return has been 9.89%.
News
Investing In Health Stocks - How Policy Clarity Is Opening Doors
The healthcare sector has experienced one of its most significant de-ratings in 35 years, with valuations now at a 30% discount to the broader market. Healthcare trades at historical valuation discoun...
The Healthcare Stock Play That Could Make Millennials Rich
If a millennial were to ask me what healthcare stock they might buy in order to get rich, I could think of several to name. But as with most stocks, I couldn't be confident that they'd still be perfor...
VHT: Passive Health Care Exposure With Conservative Growth
VHT offers broad, low-cost healthcare exposure with a market-cap weighted approach, favoring large caps but including some small innovators. The ETF is best suited as a core, defensive allocation, ben...
VHT: Health Care Sector Bruised Again In July, Spotting Possible Support (Rating Downgrade)
VHT is attractively valued at 16x forward earnings, but sector momentum is weak and technicals remain bearish. Healthcare sector underperforms YTD, with key holdings like UNH and LLY facing significan...
Here's Why Vanguard's Worst-Performing Sector ETF Is a No-Brainer Buy Right Now
Just a few months ago, healthcare was the third-highest-weighted sector in the S&P 500 behind only technology and financials. But healthcare has been drastically underperforming the S&P 500 to the poi...
VHT Looks Attractive, And Risks May Be Overestimated
Healthcare stock valuations are struggling to rise due to political risk and scandals, but this could create attractive entry points for long-term investors. And the reason lies in the bearish narrati...
China Trade Progress: Market Booms On News, Who Will Benefit?
The U.S. and China agreed to reduce tariffs on each other's goods for 90 days, boosting global equity markets and easing trade tensions. U.S. tariffs on Chinese imports will drop from 145% to 30%, whi...
Best blue-chip ETFs to buy as Donald Trump's trade war escalates
American stocks have crashed this year, and are continuing to lag behind their global peers in countries like Germany, France, and China. This performance may continue next week when Trump implements ...
VHT: Strong Growth Outlook, But Still Overpriced
Vanguard Health Care ETF (VHT) is rated a hold due to high valuations and low profitability of top holdings despite strong healthcare sector growth potential. VHT's top holdings, Eli Lilly, UnitedHeal...
Investors Are Flocking to These 3 Vanguard Sector ETFs. Should You Buy Them Too?
Following the crowd has been disparaged quite a bit in the past. But sometimes the crowd knows what it's doing.
Trump Tariffs and the Nasdaq Correction Have Been No Match for These Stock Market Sectors
The S&P 500 (SNPINDEX: ^GSPC) is cooling off after rip-roaring gains of over 20% in both 2023 and 2024.
These Vanguard ETFs Show Where the Smart Money Is Moving Now
Don't discount the power of momentum. Some studies have found that momentum trading -- buying stocks or exchange-traded funds (ETFs) that are going up -- often works over the short to medium term.
Prediction: 2 Brilliant Vanguard Index Funds Will Continue to Beat the S&P 500 in 2025
The S&P 500 (SNPINDEX: ^GSPC) is widely considered the best gauge for the overall U.S. stock market due to its scope and diversity. It measures the performance of 500 large-cap companies across all 11...
Seeking Stocks With Vitality In The Volatile Healthcare Sector
Investors cooled to the healthcare sector in 2024, which dramatically trailed global and US equity markets for the year. any investors are now asking: how will the policy changes under a new US admini...
Prediction: The 2 Best Vanguard Index Funds in January Will Beat the S&P 500 in 2025
January has historically been a strong month for the U.S. stock market, and that has remained true in 2025. The S&P 500 (SNPINDEX: ^GSPC) advanced 2.7% in January despite headwinds from elevated Treas...
VHT: A Better Choice For Health Care Assets
VHT is a low-cost index fund providing broad exposure to U.S. health care companies and is currently trading 12% below 52-week lows. The fund tracks the MSCI US IMI Health Care 25/50 Index, encompassi...
VHT: Valuation Is An Issue
VHT offers exposure to 400 healthcare companies and its biggest sector allocations are in biotechnology, pharmaceuticals, and healthcare equipment. It has outperformed the market in the past, showing ...
Why Are These 3 Vanguard ETFs Underperforming the S&P 500 Since Election Day?
Stocks in these "safe" sectors are selling off as investors gravitate toward growth.
Can You Lose Money Investing in ETFs? 3 Things to Know.
An ETF is a basket of securities bundled together into a single investment. ETFs can be a safer and less research-intensive way to invest in the stock market.
VHT Is Breaking Out On Healthcare Strength (Technical Analysis)
The healthcare industry shows consistent growth and resilience, driven by medical advancements and aging demographics, making long-term investing in healthcare sensible. VHT offers diversified exposur...
VHT: With Recession Risks Rising, It's Time To Play Defense With Healthcare
Vanguard Health Care ETF focuses on investing in successful healthcare companies with $20 billion in assets and a low expense ratio of 0.10%. Top holdings include Eli Lilly, UnitedHealth Group, and Jo...
2 Vanguard Funds Perfectly Positioned for the AI Revolution
Artificial intelligence will redraw the rules and core operating principles for most sectors -- especially healthcare and technology. These two Vanguard ETFs are a great way to gain exposure to this e...
VHT: A Cheap And Easy Way To Access Healthcare
The health care sector shows promising growth and potential for significant returns, dominated by GLP-1 weight loss hype. Vanguard Health Care Index Fund ETF Shares tracks the performance of the MSCI ...
Worried About a Market Correction? These 2 Defensive Vanguard Funds Are Pefect Safe Havens.
The U.S. stock market recently reached an all-time high, but some signs indicate a correction could be brewing. These two defensive Vanguard funds should outperform in the event of a marketwide correc...
VHT: Well-Positioned Fund In A Promising Sector, But Mediocre Compared To Peers
Vanguard's Health Care ETF has slightly underperformed peer healthcare funds and risks underperforming looking forward due to its current mix of holdings. VHT is broadly diversified, resulting in a lo...
Healthcare In 2024: Navigating The Biopharma Bull Run
The healthcare sector presents a unique investment opportunity in 2024 due to attractive valuation and uncorrelated/robust cashflow of healthcare. Biopharma companies have pricing power and ability to...
Catalyst Watch: Cigna, Humana Deal Would Face Regulatory Hurdles
Economists expect a rise of about 175,000 in non-farm payrolls. Broadcom and Lululemon are set to report earnings, with analysis focused on Broadcom's relationship with Google and Lululemon's success ...
8 Trillion Reasons to Buy and Hold This Vanguard ETF
Vanguard ETFs tend to outperform their peers and the broader markets over long periods of time. While 2023 hasn't been a banner year, the Vanguard Health Care Index Fund seems poised for a sharp trend...
VHT: Current Valuation Not Justified Due To Declining Long-Term Earnings Growth Forecast
VHT offers better downside protection than the broader market but its long-term earnings growth is in a declining trend. VHT's valuation is not attractive relative to the S&P 500 index. Valuation comp...
Bull Market or Recession? 2 Resilient Index Funds That Are Proven Moneymakers to Buy Now and Hold Forever (No Matter What Comes Next)
The Vanguard S&P 500 ETF and the Vanguard Health Care ETF have consistently made money over long periods of time. The broadly diversified Vanguard S&P 500 ETF returned 207% over the last decade, or 11...
VHT: Overweight Health Care As It Makes Its Seasonal Dip
Health Care sector has shown recent relative strength in the last month after a poor start to the year versus the S&P 500. Vanguard Health Care sector ETF is recommended with low expense ratio and sol...
XLV Vs. VHT: A Head-To-Head Healthcare ETF Comparison
The Health Care Select Sector SPDR ETF and the Vanguard Health Care ETF are the two most popular Health Care ETFs, with a combined $57 billion in assets under management. Both ETFs have a 0.10% expens...
VHT: Why Vanguard's Healthcare ETF Outperformed Last Week
Vanguard's cost-efficient (0.10% expense fee) Health Care ETF is an excellent defensively-oriented fund to hold during challenging economic times. That being the case, the VHT ETF significantly outper...
Vanguard ETFs: Recommendations For 2023
Expert recommendations for choosing among the myriad of Vanguard ETFs may prove to be a valuable resource to investors, even if not all of them will prove right. I present such recommendations made by...
VHT: You Won't Get Defensive Healthcare Exposure Here
Healthcare is considered a defensive sector and due to the brand name and cheap exposure, Vanguard's ETF prima-facie looks like a promising idea. However, outsized exposure to pharmaceuticals and biot...
VHT: 2 Megatrends In Healthcare
An aging population is expected to boost the demand for healthcare over the next few decades. The potential to reduce time and cost using AI in healthcare is an absolute game changer for the industry.
14 High-Yield Blue-Chips Perfect For 2023
The first few months of 2023 could see stocks fall 10% to 23%, and a lot of investors could make disastrous mistakes. Low-volatility high-yield blue-chips are a great way to stay invested and profit f...
VHT Vs. XLV: Picking A Winner In The Health Care Sector
In August, I wrote an article entitled The World Of 4,818 Faces An Uncertain Future. In such an environment, I believe the Health Care sector is worthy of your consideration. In this article, I draw f...
2 Dividend Blue-Chips Perfect For 2023
Most investors, economists, CEOs, and the bond market are confident a recession is coming in 2023. That means potentially another 15% to 20% downside risk for the market. Consumer staples, healthcare,...
How I Built A $3 Million High-Yield Portfolio With 11 Blue-Chips
Putting new money to work in a bear market can be terrifying, whether you have $3,000 or $3 million. But history is clear that buying blue-chip bargains in a bear market can make you rich.
What The Inflation Reduction Act Means For Drug Prices
The recently enacted Inflation Reduction Act looks to rein in prescription drug prices and could impact the pharma industry's long-term financial performance. The legislation caps out-of-pocket costs ...